Home › Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis clinical trials recruiting in the U.S.
6 studies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis are recruiting participants at sites across the United States.
Cities with the most studies
By state
- California4 studies
- Florida3 studies
- Minnesota3 studies
- New York3 studies
- North Carolina3 studies
- Ohio3 studies
Recently updated studies
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RecruitingObservational studyHealthy volunteers welcome
Ages 3 and older · All sexes · Updated Oct 1, 2026 · NCT02257866A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Sep 30, 2026 · NCT06072482FT839 in Autoimmune Diseases
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT07800871A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jul 27, 2026 · NCT07089121A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.